Diversified Trust Co Purchases Shares of 3,194 Globe Life Inc. (NYSE:GL)

Diversified Trust Co bought a new stake in shares of Globe Life Inc. (NYSE:GL) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 3,194 shares of the company’s stock, valued at approximately $356,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. UMB Bank n.a. lifted its holdings in shares of Globe Life by 7.7% during the 3rd quarter. UMB Bank n.a. now owns 1,357 shares of the company’s stock worth $144,000 after acquiring an additional 97 shares during the period. Thrivent Financial for Lutherans boosted its holdings in Globe Life by 4.0% during the third quarter. Thrivent Financial for Lutherans now owns 3,524 shares of the company’s stock valued at $373,000 after purchasing an additional 136 shares in the last quarter. Fiduciary Trust Co grew its stake in shares of Globe Life by 2.3% in the 3rd quarter. Fiduciary Trust Co now owns 6,329 shares of the company’s stock valued at $670,000 after purchasing an additional 144 shares during the period. Farther Finance Advisors LLC raised its holdings in shares of Globe Life by 4.8% in the 3rd quarter. Farther Finance Advisors LLC now owns 3,607 shares of the company’s stock worth $382,000 after buying an additional 166 shares in the last quarter. Finally, TrueWealth Advisors LLC lifted its position in shares of Globe Life by 1.3% during the 3rd quarter. TrueWealth Advisors LLC now owns 13,141 shares of the company’s stock worth $1,392,000 after buying an additional 170 shares during the period. Institutional investors own 81.61% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Truist Financial boosted their price objective on Globe Life from $90.00 to $105.00 and gave the stock a “hold” rating in a research note on Friday, October 25th. Morgan Stanley raised their target price on shares of Globe Life from $110.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Piper Sandler upped their target price on shares of Globe Life from $118.00 to $130.00 and gave the company an “overweight” rating in a research report on Friday, October 25th. Raymond James lifted their price objective on Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, October 15th. Finally, Evercore ISI upgraded Globe Life from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $132.00 to $143.00 in a report on Wednesday. Four investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $134.00.

Insider Activity at Globe Life

In other Globe Life news, Director Mark A. Blinn sold 3,000 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the completion of the sale, the director now owns 5,122 shares of the company’s stock, valued at $579,964.06. The trade was a 36.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 14,340 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $108.80, for a total transaction of $1,560,192.00. Following the transaction, the chief executive officer now directly owns 16,396 shares in the company, valued at $1,783,884.80. This represents a 46.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 39,788 shares of company stock worth $4,429,779 in the last ninety days. 1.51% of the stock is owned by company insiders.

Globe Life Trading Down 1.4 %

Globe Life stock opened at $112.51 on Friday. The stock has a 50-day simple moving average of $109.06 and a 200 day simple moving average of $102.09. The stock has a market capitalization of $9.44 billion, a P/E ratio of 9.52 and a beta of 0.80. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. Globe Life Inc. has a 52 week low of $38.95 and a 52 week high of $132.00.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, October 23rd. The company reported $3.49 earnings per share for the quarter, topping analysts’ consensus estimates of $3.06 by $0.43. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.46 billion. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. The firm’s revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.71 EPS. Analysts expect that Globe Life Inc. will post 12.31 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Monday, January 6th will be paid a dividend of $0.24 per share. The ex-dividend date of this dividend is Monday, January 6th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.85%. Globe Life’s dividend payout ratio (DPR) is currently 8.12%.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.